Modeling human hematopoietic cell development from pluripotent stem cells

Experimental Hematology

Volumn 40, Issue 8, 2012, Pages 601-611

  Kardel, Melanie D ^a   Eaves, Connie J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN; WNT PROTEIN;

CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SUSPENSION; CELL TRACKING; CULTURE TECHNIQUE; EMBRYO DEVELOPMENT; EMBRYOID BODY; EMBRYONIC STEM CELL; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; MESODERM; MOUSE EMBRYO; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MESODERM; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS;

MUS;

EID: 84864023350     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.04.001     Document Type: Review

References (143)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
2. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
3. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
4. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
5. Kanatsu M., Nishikawa S.I. In vitro analysis of epiblast tissue potency for hematopoietic cell differentiation. Development 1996, 122:823-830.
6. Kinder S.J., Tsang T.E., Quinlan G.A., Hadjantonakis A.K., Nagy A., Tam P.P. The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development 1999, 126:4691-4701.
7. Gadue P., Huber T.L., Nostro M.C., Kattman S., Keller G.M. Germ layer induction from embryonic stem cells. Exp Hematol 2005, 33:955-964.
8. Huber T.L., Kouskoff V., Fehling H.J., Palis J., Keller G. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 2004, 432:625-630.
9. Nishikawa S.I., Nishikawa S., Kawamoto H., et al. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity 1998, 8:761-769.
10. Boisset J.C., van Cappellen W., Andrieu-Soler C., Galjart N., Dzierzak E., Robin C. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010, 464:116-120.
11. Moore M.A., Metcalf D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970, 18:279-296.
12. Palis J., Robertson S., Kennedy M., Wall C., Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 1999, 126:5073-5084.
13. Godin I., Dieterlen-Lievre F., Cumano A. Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. Proc Natl Acad Sci U S A 1995, 92:773-777.
14. Alvarez-Silva M., Belo-Diabangouaya P., Salaun J., Dieterlen-Lievre F. Mouse placenta is a major hematopoietic organ. Development 2003, 130:5437-5444.
15. Gekas C., Dieterlen-Lievre F., Orkin S.H., Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev Cell 2005, 8:365-375.
16. Medvinsky A.L., Samoylina N.L., Muller A.M., Dzierzak E.A. An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 1993, 364:64-67.
17. Kumaravelu P., Hook L., Morrison A.M., et al. Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development 2002, 129:4891-4899.
18. Muller A.M., Medvinsky A., Strouboulis J., Grosveld F., Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994, 1:291-301.
19. McGrath K.E., Koniski A.D., Malik J., Palis J. Circulation is established in a stepwise pattern in the mammalian embryo. Blood 2003, 101:1669-1676.
20. Dzierzak E., Speck N.A. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol 2008, 9:129-136.
21. Bloom W., Bartelmez G.W. Hematopoiesis in young human embryos. Am J Anat 1940, 67:21-53.
22. Luckett W.P. Origin and differentiation of the yolk sac and extraembryonic mesoderm in presomite human and rhesus monkey embryos. Am J Anat 1978, 152:59-97.
23. Robin C., Bollerot K., Mendes S., et al. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 2009, 5:385-395.
24. Tavian M., Hallais M.F., Peault B. Emergence of intraembryonic hematopoietic precursors in the pre-liver human embryo. Development 1999, 126:793-803.
25. Lensch M.W., Daley G.Q. Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models. Curr Top Dev Biol 2004, 60:127-196.
26. Tavian M., Robin C., Coulombel L., Peault B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 2001, 15:487-495.
27. Ivanovs A., Rybtsov S., Welch L., Anderson R.A., Turner M.L., Medvinsky A. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J Exp Med 2011, 208:2417-2427.
28. Labastie M.C., Cortes F., Romeo P.H., Dulac C., Peault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood 1998, 92:3624-3635.
29. Jokubaitis V.J., Sinka L., Driessen R., et al. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 2008, 111:4055-4063.
30. Oberlin E., Fleury M., Clay D., et al. VE-cadherin expression allows identification of a new class of hematopoietic stem cells within human embryonic liver. Blood 2010, 116:4444-4455.
31. Oberlin E., Tavian M., Blazsek I., Peault B. Blood-forming potential of vascular endothelium in the human embryo. Development 2002, 129:4147-4157.
32. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
33. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981, 78:7634-7638.
34. Brons I.G., Smithers L.E., Trotter M.W., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
35. Tesar P.J., Chenoweth J.G., Brook F.A., et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
36. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
37. Nakano T., Kodama H., Honjo T. In vitro development of primitive and definitive erythrocytes from different precursors. Science 1996, 272:722-724.
38. Dang S.M., Kyba M., Perlingeiro R., Daley G.Q., Zandstra P.W. Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. Biotechnol Bioeng 2002, 78:442-453.
39. Keller G., Kennedy M., Papayannopoulou T., Wiles M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 1993, 13:473-486.
40. Cho S.K., Bourdeau A., Letarte M., Zuniga-Pflucker J.C. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood 2001, 98:3635-3642.
41. Keller G.M. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 1995, 7:862-869.
42. Kitajima K., Minehata K., Sakimura K., Nakano T., Hara T. In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2. Blood 2011, 117:3748-3758.
43. Kyba M., Perlingeiro R.C., Daley G.Q. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002, 109:29-37.
44. Matsumoto K., Isagawa T., Nishimura T., et al. Stepwise development of hematopoietic stem cells from embryonic stem cells. PLoS One 2009, 4:e4820.
45. Schuringa J.J., Wu K., Morrone G., Moore M.A. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo. Stem Cells 2004, 22:1191-1204.
46. Wang Y., Yates F., Naveiras O., Ernst P., Daley G.Q. Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci U S A 2005, 102:19081-19086.
47. Perlingeiro R.C., Kyba M., Daley G.Q. Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid-myeloid potential. Development 2001, 128:4597-4604.
48. Robertson S.M., Kennedy M., Shannon J.M., Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 2000, 127:2447-2459.
49. Kouskoff V., Lacaud G., Schwantz S., Fehling H.J., Keller G. Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A 2005, 102:13170-13175.
50. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998, 125:725-732.
51. Faloon P., Arentson E., Kazarov A., et al. Basic fibroblast growth factor positively regulates hematopoietic development. Development 2000, 127:1931-1941.
52. Fehling H.J., Lacaud G., Kubo A., et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003, 130:4217-4227.
53. Kennedy M., Firpo M., Choi K., et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 1997, 386:488-493.
54. Irion S., Clarke R.L., Luche H., et al. Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells. Development 2010, 137:2829-2839.
55. Gadue P., Huber T.L., Paddison P.J., Keller G.M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci U S A 2006, 103:16806-16811.
56. Johansson B.M., Wiles M.V. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995, 15:141-151.
57. Nostro M.C., Cheng X., Keller G.M., Gadue P. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2008, 2:60-71.
58. Park C., Afrikanova I., Chung Y.S., et al. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 2004, 131:2749-2762.
59. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997, 89:981-990.
60. Fujiwara Y., Browne C.P., Cunniff K., Goff S.C., Orkin S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A 1996, 93:12355-12358.
61. Pevny L., Simon M.C., Robertson E., et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991, 349:257-260.
62. Simon M.C., Pevny L., Wiles M.V., Keller G., Costantini F., Orkin S.H. Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells. Nat Genet 1992, 1:92-98.
63. Lugus J.J., Chung Y.S., Mills J.C., et al. GATA2 functions at multiple steps in hemangioblast development and differentiation. Development 2007, 134:393-405.
64. Tsai F.Y., Keller G., Kuo F.C., et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994, 371:221-226.
65. Tsai F.Y., Orkin S.H. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 1997, 89:3636-3643.
66. D'Souza S.L., Elefanty A.G., Keller G. SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood 2005, 105:3862-3870.
67. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 1996, 86:47-57.
68. Robb L., Elwood N.J., Elefanty A.G., et al. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. Embo J 1996, 15:4123-4129.
69. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 1995, 373:432-434.
70. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
71. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A 1996, 93:3444-3449.
72. Hanna J., Wernig M., Markoulaki S., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
73. Schenke-Layland K., Rhodes K.E., Angelis E., et al. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008, 26:1537-1546.
74. Choi K.D., Yu J., Smuga-Otto K., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009, 27:559-567.
75. Lengerke C., Grauer M., Niebuhr N.I., et al. Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci 2009, 1176:219-227.
76. Lu M., Kardel M.D., O'Connor M.D., Eaves C.J. Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp Hematol 2009, 37:924-936.
77. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2001, 98:10716-10721.
78. Kennedy M., D'Souza S.L., Lynch-Kattman M., Schwantz S., Keller G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007, 109:2679-2687.
79. Ledran M.H., Krassowska A., Armstrong L., et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 2008, 3:85-98.
80. Vodyanik M.A., Bork J.A., Thomson J.A., Slukvin Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005, 105:617-626.
81. Lu S.J., Feng Q., Park J.S., et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008, 112:4475-4484.
82. Ma F., Ebihara Y., Umeda K., et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A 2008, 105:13087-13092.
83. Qiu C., Olivier E.N., Velho M., Bouhassira E.E. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood 2008, 111:2400-2408.
84. Zambidis E.T., Peault B., Park T.S., Bunz F., Civin C.I. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005, 106:860-870.
85. Cerdan C., Rouleau A., Bhatia M. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 2004, 103:2504-2512.
86. Davis R.P., Ng E.S., Costa M., et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 2008, 111:1876-1884.
87. Lu S.J., Feng Q., Caballero S., et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007, 4:501-509.
88. Wang L., Li L., Shojaei F., et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004, 21:31-41.
89. Lu S.J., Feng Q., Ivanova Y., et al. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev 2007, 16:547-559.
90. Tian X., Woll P.S., Morris J.K., Linehan J.L., Kaufman D.S. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 2006, 24:1370-1380.
91. Wang L., Menendez P., Shojaei F., et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 2005, 201:1603-1614.
92. Narayan A.D., Chase J.L., Lewis R.L., et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2006, 107:2180-2183.
93. Holyoake T.L., Nicolini F.E., Eaves C.J. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999, 27:1418-1427.
94. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisica I., Dick J.E. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
95. Kaufman D.S. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood 2009, 114:3513-3523.
96. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005, 23:1534-1541.
97. Vallier L., Touboul T., Chng Z., et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 2009, 4:e6082.
98. Zhang P., Li J., Tan Z., et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 2008, 111:1933-1941.
99. Niwa A., Heike T., Umeda K., et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS One 2011, 6:e22261.
100. Lake J., Rathjen J., Remiszewski J., Rathjen P.D. Reversible programming of pluripotent cell differentiation. J Cell Sci 2000, 113(Pt 3):555-566.
101. Rathjen J., Lake J.A., Bettess M.D., Washington J.M., Chapman G., Rathjen P.D. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell Sci 1999, 112:601-612.
102. Calhoun J.D., Rao R.R., Warrenfeltz S., et al. Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem Biophys Res Commun 2004, 323:453-464.
103. Pick M., Azzola L., Mossman A., Stanley E.G., Elefanty A.G. Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 2007, 25:2206-2214.
104. Chadwick K., Wang L., Li L., et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
105. Zambidis E.T., Park T.S., Yu W., et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008, 112:3601-3614.
106. Tian X., Morris J.K., Linehan J.L., Kaufman D.S. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol 2004, 32:1000-1009.
107. Lu S.J., Luo C., Holton K., Feng Q., Ivanova Y., Lanza R. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regen Med 2008, 3:693-704.
108. Wang C., Tang X., Sun X., et al. TGFbeta inhibition enhances the generation of hematopoietic progenitors from human ES cell-derived hemogenic endothelial cells using a stepwise strategy. Cell Res 2012, 22:194-207.
109. Wang Y., Nakayama N. WNT and BMP signaling are both required for hematopoietic cell development from human ES cells. Stem Cell Res 2009, 3:113-125.
110. Woll P.S., Morris J.K., Painschab M.S., et al. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008, 111:122-131.
111. Vijayaragavan K., Szabo E., Bosse M., Ramos-Mejia V., Moon R.T., Bhatia M. Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 2009, 4:248-262.
112. Bhatia M., Bonnet D., Kapp U., Wang J.C., Murdoch B., Dick J.E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997, 186:619-624.
113. Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A 1997, 94:9836-9841.
114. Zandstra P.W., Conneally E., Piret J.M., Eaves C.J. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells. Br J Haematol 1998, 101:770-778.
115. Bowles K.M., Vallier L., Smith J.R., Alexander M.R., Pedersen R.A. HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells 2006, 24:1359-1369.
116. Qiu C., Hanson E., Olivier E., et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005, 33:1450-1458.
117. Ng E.S., Davis R.P., Azzola L., Stanley E.G., Elefanty A.G. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 2005, 106:1601-1603.
118. Gonzalez F., Boue S., Izpisua Belmonte J.C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 2011, 12:231-242.
119. Ghosh Z., Wilson K.D., Wu Y., Hu S., Quertermous T., Wu J.C. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 2010, 5:e8975.
120. Kim K., Zhao R., Doi A., et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2011, 29:1117-1119.
121. Chan E.M., Ratanasirintrawoot S., Park I.H., et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009, 27:1033-1037.
122. Adewumi O., Aflatoonian B., Ahrlund-Richter L., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007, 25:803-816.
123. Akopian V., Andrews P.W., Beil S., et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. Vitro Cell Dev Biol Anim 2010, 46:247-258.
124. Hirst M., Delaney A., Rogers S.A., et al. LongSAGE profiling of nine human embryonic stem cell lines. Genome Biol 2007, 8:R113.
125. Liu Y., Shin S., Zeng X., et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of US Federal government approved hESC lines. BMC Dev Biol 2006, 6:20.
126. Feng Q., Lu S.J., Klimanskaya I., et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010, 28:704-712.
127. Ramos-Mejia V., Melen G.J., Sanchez L., et al. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther 2010, 18:2173-2181.
128. Peerani R., Rao B.M., Bauwens C., et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. Embo J 2007, 26:4744-4755.
129. Lu J., Hou R., Booth C.J., Yang S.H., Snyder M. Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci U S A 2006, 103:5688-5693.
130. Ludwig T.E., Bergendahl V., Levenstein M.E., Yu J., Probasco M.D., Thomson J.A. Feeder-independent culture of human embryonic stem cells. Nat Methods 2006, 3:637-646.
131. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005, 118:4495-4509.
132. Xu C., Rosler E., Jiang J., et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 2005, 23:315-323.
133. Yao S., Chen S., Clark J., et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci U S A 2006, 103:6907-6912.
134. Villegas S.N., Canham M., Brickman J.M. FGF signalling as a mediator of lineage transitions-evidence from embryonic stem cell differentiation. J Cell Biochem 2010, 110:10-20.
135. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009, 27:275-280.
136. Ng E.S., Davis R., Stanley E.G., Elefanty A.G. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc 2008, 3:768-776.
137. Buzzard J.J., Gough N.M., Crook J.M., Colman A. Karyotype of human ES cells during extended culture. Nat Biotechnol 2004, 22:381-382. author reply 382.
138. Chan E.M., Yates F., Boyer L.F., Schlaeger T.M., Daley G.Q. Enhanced plating efficiency of trypsin-adapted human embryonic stem cells is reversible and independent of trisomy 12/17. Cloning Stem Cells 2008, 10:107-118.
139. Ellerstrom C., Strehl R., Noaksson K., Hyllner J., Semb H. Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells 2007, 25:1690-1696.
140. Hasegawa K., Fujioka T., Nakamura Y., Nakatsuji N., Suemori H. A method for the selection of human embryonic stem cell sublines with high replating efficiency after single-cell dissociation. Stem Cells 2006, 24:2649-2660.
141. Hong S.H., Rampalli S., Lee J.B., et al. Cell fate potential of human pluripotent stem cells is encoded by histone modifications. Cell Stem Cell 2011, 9:24-36.
142. Gerrits A., Dykstra B., Kalmykowa O.J., et al. Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 2010, 115:2610-2618.
143. Jordan C.T., Lemischka I.R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 1990, 4:220-232.